Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: The evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial

Circulation

Volumn 132, Issue 1, 2015, Pages 27-39

  Moe, Sharon M ^a   Chertow, Glenn M ^b   Parfrey, Patrick S ^c   Kubo, Yumi ^d   Block, Geoffrey A ^e   Correa Rotter, Ricardo ^f   Drüeke, Tilman B ^g   Herzog, Charles A ^h   London, Gerard M ⁱ   Mahaffey, Kenneth W ^b   Wheeler, D ^l   Stolina, Maria ^d   Dehmel, Bastian ^d   Goodman, William G ^d   Floege, Jürgen ^k   Santos, J ^l   Najun Zarazaga, C ^l   Marin, I ^l   Garrote, N ^l   Cusumano, A ^l   Penalba N ^l   Del Valle, E ^l   Juncos, L ^l   Martinez Saye, J ^l   Lef, L ^l   Altobelli, V ^l   Petraglia, G ^l   Rosa Diez, G ^l   Douthat, W ^l   Lobo, J ^l   Gallart, C ^l   Lafalla, A ^l   Diez, G ^l   Linares, B ^l   Lopez, N ^l   Ramirez, N ^l   Gonzalez, R ^l   Valtuille, R ^l   Beresan, H ^l   Hermida, O ^l   Rudolf, G ^l   Marchetta, N ^l   Rano, M ^l   Ramirez, M ^l   Garcia N ^l   Gillies, A ^l   Jones, B ^l   Pedagogos, E ^l   Walker, R ^l   Talaulikar, G ^l   Bannister, K ^l   Suranyi, M ^l   Kark, A ^l   Roger, S ^l   Kerr, P ^l   Disney, A ^l   Mount, P ^l   Fraenkel, M ^l   Mathew, M ^l   Fassett, R ^l   Jose, M ^l   Hawley, C ^l   Lonergan, M ^l   Mackie, J ^l   Ferrari, P ^l   Menahem, S ^l   Sabto, J ^l   Hutchison, B ^l   Langham, R ^l   Pollock, C ^l   Holzer, H ^l   Oberbauer, R ^l   Arias, I ^l   Graf, H ^l   Mayer, G ^l   Lhotta, K ^l   Neyer, U ^l   Klauser, R ^l   Hoerl, W ^l   Horn, S ^l   Kovarik, J ^l   Kramar, R ^l   Eigner, M ^l   Dhaene, M ^l   Billiouw, J ^l   De Meester, J ^l   Warling, X ^l   Cambier Dwelschauwers, P ^l   Evenepoel, P ^l   Daelemans, R ^l   Dratwa, M ^l   Maes, B ^l   Stolear, J ^l   Dejagere, T ^l   Vanwalleghem, J ^l   Bouman, K ^l   Jadoul, M ^l   Peeters, J ^l   Vanholder, R ^l   Tielemans, C ^l   Donck, J ^l   Almeida, F ^l   Picollo De Oliveira, J ^l   Burdmann, E ^l   Garcia, V ^l   Saldanha Thome, F ^l   Deboni, L ^l   Bregman, R ^l   Lugon, J ^l   Araujo S ^l   Ferreira Filho, S ^l   De Francesco Daher, E ^l   Sperto Baptista, M ^l   Carvalho, A ^l   D'Avila, D ^l   Moyses Neto, M ^l   Yu, L ^l   Bastos, M ^l   Sampaio Lacativa, P ^l   Jorgetti, V ^l   De Almeida Romao E ^l   Cardeal Da Costa, J ^l   Pecoits Filho, R ^l   Gordan, P ^l   Salgado, N ^l   Teixeira Araujo M ^l   Neiva Coelho, S ^l   Oliveira, I ^l   Moyses R ^l   Vasconcellos, L ^l   Batista, P ^l   Luiz Gross, J ^l   Pedrosa, A ^l   Cournoyer, S ^l   LeBlanc, M ^l   Chow, S ^l   Karunakaran, S ^l   Wong, G ^l   Tobe, S ^l   Desmeules, S ^l   Zimmerman, D ^l   Murphy, S ^l   Montambault, P ^l   Donnelly, S ^l   MacRae, J ^l   Culleton, B ^l   Soroka, S ^l   Rabbat, C ^l   Jindal, K ^l   Vasilevsky, M ^l   Michaud, M ^l   Wijeyesinghe, E ^l   Zacharias, J ^l   Lok, C ^l   Muirhead, N ^l   Verrelli, M ^l   Da Roza, G ^l   Sapir, D ^l   Olgaard, K ^l   Daugaard, H ^l   Brandi, L ^l   Jensen, P ^l   Boulechfar, H ^l   Ang, K ^l   Simon, P ^l   Rieu, P ^l   Brunet, P ^l   Touchard, G ^l   Urena Torres, P ^l   Combe, C ^l   Durrbach, A ^l   Ortiz, J ^l   Hannedouche, T ^l   Vela, C ^l   Lionet, A ^l   Ryckelynck, P ^l   Zaoui, P ^l   Choukroun, G ^l   Fessi, H ^l   Lang, P ^l   Stroumza, P ^l   Joly, D ^l   Mousson, C ^l   Laville, M ^l   Dellanna, F ^l   Erley, C ^l   Braun, J ^l   Rambausek, M ^l   Riegel, W ^l   Klingberg, M ^l   Schwertfeger, E ^l   Wizemann, V ^l   Eckardt, K ^l   Reichel, H ^l   Passauer, J ^l   Hubel E ^l   Frischmuth, N ^l   Liebl, R ^l   Fiedler, R ^l   Schwenger, V ^l   Vosskuhler A ^l   Kunzendorf, U ^l   Renders, L ^l   Rattensberger, D ^l   Rump, L ^l   Ketteler, M ^l   Neumayer, H ^l   Zantvoort, F ^l   Stahl, R ^l   Ladanyi, E ^l   Kulcsar, I ^l   Mezei, I ^l   Csiky, B ^l   Rikker, C ^l   Arkossy, O ^l   Berta, K ^l   Szegedi, J ^l   Major, L ^l   Ferenczi, S ^l   Fekete, A ^l   Szabo, T ^l   Zakar, G ^l   Wagner, G ^l   Kazup Erdelyine, S ^l   Borbas, B ^l   Eustace, J ^l   Reddan, D ^l   Capasso, G ^l   Locatelli, F ^l   Villa, G ^l   Cozzolino, M ^l   Brancaccio, D ^l   Messa, P ^l   Bolasco, P ^l   Ricciardi, B ^l   Malberti, F ^l   Moriero, E ^l   Cannella, G ^l   Ortalda, V ^l   Stefoni, S ^l   Frasca G ^l   Cappelli, G ^l   Albertazzi, A ^l   Zoccali, C ^l   Farina, M ^l   Elli, A ^l   Avella, F ^l   Ondei, P ^l   Mingardi, G ^l   Errico, R ^l   Losito, A ^l   Di Giulio, S ^l   Pertosa, G ^l   Schena, F ^l   Grandaliano, G ^l   Gesualdo, L ^l   Auricchio, M ^l   Bochicchio Ricardelli, T ^l   Aranda Verastegui F ^l   Pena J ^l   Chew Wong, A ^l   Cruz Valdez, J ^l   Torres Zamora, M ^l   Solis, M ^l   Sebastian Diaz, M ^l   Vital Flores, M ^l   Alvarez Sandoval, E ^l   Van Den Dorpel, M ^l   Brink, H ^l   Van Kuijk, W ^l   Vermeij, C ^l   Smak Gregoor, P ^l   Hagen, E ^l   Van Der Sande, F ^l   Klinger, M ^l   Nowicki, M ^l   Muszytowski, M ^l   Bidas, K ^l   Bentkowski, W ^l   Wiecek, A ^l   Ksiazek, A ^l   Marczewski, K ^l   Ostrowski, M ^l   Switalski, M ^l   Sulowicz, W ^l   Matuszkiewicz Rowinska, J ^l   Mysliwiec, M ^l   Durlik, M ^l   Rutkowski, B ^l   Macario, F ^l   Carvalho, B ^l   Frazao, J ^l   Machado, D ^l   Weigert, A ^l   Andrusev, A ^l   Khrustalev, O ^l   Zemtchenkov, A ^l   Gurevich, K ^l   Staroselsky, K ^l   Khadikova, N ^l   Rozhinskaya, L ^l   Timokhovskaya, G ^l   Strokov, A ^l   Balkarova, O ^l   Ermolenko, V ^l   Kolmakova, E ^l   Komandenko, M ^l   Timofeev, M ^l   Shilo, V ^l   Shostka, G ^l   Smirnov, A ^l   Anashkin, V ^l   Volgina, G ^l   Domashenko, O ^l   Gurevich, A ^l   Perlin, D ^l   Martinez Garcia J ^l   Andres Ribes E ^l   Coll Piera, E ^l   Fernandez Lucas, M ^l   Galicia, M ^l   Prados, M ^l   Gonzalez M ^l   Romero, R ^l   Martin de Francisco A ^l   Montenegro, J ^l   Santiago, C ^l   Garcia F ^l   Alcazar De La Ossa J ^l   Arrieta, J ^l   Pons, J ^l   Martin Malo A ^l   Soler Amigo J ^l   Cases, A ^l   Sterner, G ^l   Jensen, G ^l   Wikstrom B ^l   Jacobson, S ^l   Lund, U ^l   Weiss, L ^l   Stahl, A ^l   Von Albertini, B ^l   Burnier, M ^l   Meier, P ^l   Martin, P ^l   Uehlinger, D ^l   Dickenmann, M ^l   Yaqoob, M ^l   Zehnder, D ^l   Kalra, P ^l   Padmanabhan, N ^l   Roe, S ^l   Eadington, D ^l   Pritchard, N ^l   Hutchison, A ^l   Davies, S ^l   Wilkie, M ^l   Davies, M ^l   Pai, P ^l   Swift, P ^l   Kwan, J ^l   Goldsmith, D ^l   Tomson, C ^l   Stratton, J ^l   Dasgupta, I ^l   Sarkar, S ^l   Moustafa, M ^l   Gandhi, K ^l   Jamal, A ^l   Galindo Ramos, E ^l   Tuazon, J ^l   Batlle, D ^l   Tucker, K ^l   Schiller Moran, B ^l   Assefi, A ^l   Martinez, C ^l   Samuels, L ^l   Goldman, J ^l   Cangiano Rivera, J ^l   Darwish, R ^l   Lee, M ^l   Topf, J ^l   Kapatkin, K ^l   Baer, H ^l   Kopelman, R ^l   Acharya, M ^l   Tharpe, D ^l   Bernardo, M ^l   Nader, P ^l   Guzman Rivera, J ^l   Pergola, P ^l   Sekkarie, M ^l   Alas, E ^l   Zager, P ^l   Liss, K ^l   Navarro, J ^l   Roppolo, M ^l   Denu Ciocca, C ^l   Kshirsagar, A ^l   El Khatib, M ^l   Kant, K ^l   Scott, D ^l   Murthyr, B ^l   Finkelstein, F ^l   Keightley, G ^l   McCrary, R ^l   Pitone, J ^l   Cavalieri, T ^l   Tsang, A ^l   Pellegrino, B ^l   Schmidt, R ^l   Ahmad, S ^l   Brown, C ^l   Friedman, E ^l   Mittman, N ^l   Fadem, S ^l   Shapiro, W ^l   Reddy, M ^l   Goldberger, S ^l   Woredekal, Y ^l   Agarwal, A ^l   Anger, M ^l   Haque, M ^l   Chidester, P ^l   Kohli, R ^l   Rubinstein, S ^l   Newman, G ^l   Gladish, R ^l   Ayodeji, O ^l   Soman, S ^l   Sprague, S ^l   Hunt, N ^l   Gehr, T ^l   Rizk, D ^l   Warnock, D ^l   Polack, D ^l   Pahl, M ^l   Fischer, D ^l   Dreyer, P ^l   James, G ^l   Husserl, F ^l   Rogers, T ^l   Raff, A ^l   Sedor, J ^l   Silver, M ^l   Smith, M ^l   Steinberg, S ^l   DelGiorno, T ^l   Jones, E ^l   Cunha, P D ^l   Cheng, J ^l   Pogue, V ^l   Blumenthal, S ^l   Brown, E ^l   Charytan, C ^l   Buerkert, J ^l   Cook, M ^l   Felsenfeld, A ^l   Tareen, N ^l   Gupta, A ^l   Herman, T ^l   Diamond, S ^l   Hura, C ^l   Laski, M ^l   MacLaurin, J ^l   Plumb, T ^l   Brosnahan, G ^l   Kumar, J ^l   Henriquez, M ^l   Poole, C ^l   Osanloo, E ^l   Matalon, A ^l   Sholer, C ^l   Arfeen, S ^l   Azer, M ^l   Belledonne, M ^l   Gross, M ^l   Dunnigan, E ^l   McConnell, K ^l   Becker, B ^l   Skinner, F ^l   Rigolosi, R ^l   Spiegel, D ^l   Stegman, M ^l   Patak, R ^l   Streja, D ^l   Ranjit, U ^l   Youell, T ^l   Wooldridge, T ^l   Stafford, C ^l   Cottiero, R ^l   Weinberg, M ^l   Schonefeld, M ^l   Shahmir, E ^l   Hazzan, A ^l   Ashfaq, A ^l   Bhandari, K ^l   Cleveland, W ^l   Culpepper, M ^l   Golden, J ^l   Lai, L ^l   Lien, Y ^l   Lorica, V ^l   Robertson, J ^l   Malireddi, K ^l   Morse, S ^l   Thakur, V ^l   Israelit, A ^l   Raguram, P ^l   Alfred, H ^l   Weise, W ^l   Al Saghir, F ^l   El Shahawy, M ^l   Rastogi, A ^l   Nissenson, A ^l   Kopyt, N ^l   Lynn, R ^l   Lea, J ^l   McClellan, W ^l   Teredesai, P ^l   Ong, S ^l   Tolkan, S ^l   Sugihara, J ^l   Minga, T ^l   Mehrotra, R ^l   Minasian, R ^l   Bhatia, D ^l   Specter, R ^l   Capelli, J ^l   Sidhu, P ^l   Dalal, S ^l   Dykes, P ^l   Khan, M ^l   Rahim, F ^l   Saklayen, M ^l   Thomas, A ^l   Michael, B ^l   Torres, M ^l   Al Bander, H ^l   Murray, B ^l   Abukurah, A ^l   Gupta, B ^l   Nosrati, S ^l   Raja, R ^l   Zeig, S ^l   Braun, M ^l   Amatya, A ^l   Endsley, J ^l   Sharon, Z ^l   Dolson, G ^l   Dumler, F ^l   Ntoso, K ^l   Rosansky, S ^l   Kumar, N ^l   Gura, V ^l   Thompson, N ^l   Goldfarb, D ^l   Halligan, R ^l   Middleton, J ^l   Widerhorn, A ^l   Arbeit, L ^l   Arruda, J ^l   Crouch, T ^l   Friedman, L ^l   Khokhar, S ^l   Mittleman, J ^l   Light, P ^l   Taparia, B ^l   West, C ^l   Cotton, J ^l   Dhingra, R ^l   Kleinman, L ^l   Arif, F ^l   Lew, S ^l   Nammour, T ^l   Sterrett, J ^l   Williams, M ^l   Ramirez, J ^l   Rubin, J ^l   McCarthy, J ^l   Noble, S ^l   Chaffin, M ^l   Rekhi, A ^l   more..

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Health Sciences Centre St John's   (Canada)

^d AMGEN INC   (United States)

^e Denver Nephrology   (United States)

^f INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^g UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^h UNIVERSITY OF MINNESOTA   (United States)

ⁱ Hopital Manhes   (France)

^j UNIVERSITY COLLEGE LONDON   (United Kingdom)

^k UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^l NONE   (United States)

more..

Author keywords

arrhythmias, cardiac; calcium; death, sudden, cardiac; renal insufficiency, chronic; ventricular remodeling

Indexed keywords

CALCITRIOL; CALCIUM; CINACALCET; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHATE; PHOSPHATE BINDING AGENT; PLACEBO; VITAMIN D DERIVATIVE; FIBROBLAST GROWTH FACTOR; NAPHTHALENE DERIVATIVE;

ADD ON THERAPY; ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART INFARCTION; HEMODIALYSIS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PERIPHERAL VASCULAR DISEASE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECONDARY ANALYSIS; SECONDARY HYPERPARATHYROIDISM; SUDDEN CARDIAC DEATH; UNSTABLE ANGINA PECTORIS; BLOOD; CARDIOVASCULAR DISEASES; HYPERTHYROIDISM; MIDDLE AGED; MORTALITY; RENAL REPLACEMENT THERAPY;

ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; NAPHTHALENES; RENAL DIALYSIS;

EID: 84935451711     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.013876     Document Type: Article

References (35)

1. Isakova T, Wahl P, Vargas GS, Gutiérrez OM, Scialla J, Xie H, Appleby D, Nessel L, Bellovich K, Chen J, Hamm L, Gadegbeku C, Horwitz E, Townsend RR, Anderson CA, Lash JP, Hsu CY, Leonard MB, Wolf M. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int. 2011; 79: 1370-1378. doi: 10.1038/ki.2011.47
2. Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, Wahl P, Gutiérrez OM, Steigerwalt S, He J, Schwartz S, Lo J, Ojo A, Sondheimer J, Hsu CY, Lash J, Leonard M, Kusek JW, Feldman HI, Wolf M. Chronic Renal Insufficiency Cohort (CRIC) Study Group. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA. 2011; 305: 2432-2439. doi: 10.1001/jama.2011.826
3. Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F, Kuen E, König P, Kraatz G, Mann JF, Müller GA, Köhler H, Riegler P. MMKD Study Group Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol. 2007; 18: 2600-2608. doi: 10.1681/ASN.2006080936
4. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro-O M, Kusek JW, Keane MG, Wolf M. FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011; 121: 4393-4408. doi: 10.1172/JCI46122
5. Gutiérrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, Sarwar A, Hoffmann U, Coglianese E, Christenson R, Wang TJ, deFilippi C, Wolf M. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation. 2009; 119: 2545-2552. doi: 10.1161/CIRCULATIONAHA.108.844506
6. Seiler S, Reichart B, Roth D, Seibert E, Fliser D, Heine GH. FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment. Nephrol Dial Transplant. 2010; 25: 3983-3989. doi: 10.1093/ndt/gfq309
7. Nakano C, Hamano T, Fujii N, Obi Y, Matsui I, Tomida K, Mikami S, Inoue K, Shimomura A, Nagasawa Y, Okada N, Tsubakihara Y, Rakugi H, Isaka Y. Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis. Bone. 2012; 50: 1266-1274. doi: 10.1016/j.bone.2012.02.634
8. Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008; 359: 584-592. doi: 10.1056/NEJMoa0706130
9. Olauson H, Qureshi AR, Miyamoto T, Barany P, Heimburger O, Lindholm B, Stenvinkel P, Larsson TE. Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?. Nephrol Dial Transplant. 2010; 25: 3033-3038. doi: 10.1093/ndt/gfq191
10. Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. Nephrol Dial Transplant. 2009; 24: 2792-2796. doi: 10.1093/ndt/gfp191
11. Hsu HJ, Wu MS. Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients. Am J Med Sci. 2009; 337: 116-122. doi: 10.1097/MAJ.0b013e3181815498
12. Touchberry CD, Green TM, Tchikrizov V, Mannix JE, Mao TF, Carney BW, Girgis M, Vincent RJ, Wetmore LA, Dawn B, Bonewald LF, Stubbs JR, Wacker MJ. FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy. Am J Physiol Endocrinol Metab. 2013; 304: E863-E873. doi: 10.1152/ajpendo.00596.2012
13. Koizumi M, Komaba H, Nakanishi S, Fujimori A, Fukagawa M. Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism. Nephrol Dial Transplant. 2012; 27: 784-790. doi: 10.1093/ndt/gfr384
14. Wetmore JB, Liu S, Krebill R, Menard R, Quarles LD. Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD. Clin J Am Soc Nephrol. 2010; 5: 110-116. doi: 10.2215/CJN.03630509
15. Chertow GM, Pupim LB, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, London GM, Mahaffey KW, Moe SM, Wheeler DC, Albizem M, Olson K, Klassen P, Parfrey P. Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview. Clin J Am Soc Nephrol. 2007; 2: 898-905. doi: 10.2215/CJN.04381206
16. Chertow GM, Correa-Rotter R, Block GA, Drueke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Wheeler DC, Parfrey PS. Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial. Nephrol Dial Transplant. 2012; 27: 2872-2879. doi: 10.1093/ndt/gfr777
17. Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS. EVOLVE Trial Investigators Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med. 2012; 367: 2482-2494. doi: 10.1056/NEJMoa1205624
18. Chertow GM, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix CH, Moe SM, Trotman ML, Wheeler DC, Parfrey PS. A randomized trial of cinacalcet in patients on hemodialysis with secondary hyperparathyroidism. N Engl J Med. 2012; 367: 2482-2494. doi: 10.1056/NEJMoa1205624
19. Rothman K, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelphia, PA: Wolters Kluwer; 2012
20. Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drüeke TB, Goodman WG. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med. 2004; 350: 1516-1525. doi: 10.1056/NEJMoa031633
21. Martin KJ, González EA, Gellens M, Hamm LL, Abboud H, Lindberg J. 19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis. J Am Soc Nephrol. 1998; 9: 1427-1432
22. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003; 42(suppl 3): S1-S201
23. Kim HJ, Kim H, Shin N, Na KY, Kim YL, Kim D, Chang JH, Song YR, Hwang YH, Kim YS, Ahn C, Lee J, Oh KH. Representing the Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect of iPTH Level (CUPID) Study Group Cinacalcet lowering of serum fibroblast growth factor-23 concentration may be independent from serum Ca, P, PTH and dose of active vitamin D in peritoneal dialysis patients: a randomized controlled study. BMC Nephrol. 2013; 14: 112. doi: 10.1186/1471-2369-14-112
24. Moe SM, Chen NX, Newman CL, Gattone VH 2nd, Organ JM, Chen X, Allen MR. A comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD. J Bone Miner Res. 2014; 29: 902-910. doi: 10.1002/jbmr.2089
25. Rodriguez-Ortiz ME, Lopez I, Muñoz-Castañeda JR, Martinez-Moreno JM, Ramírez AP, Pineda C, Canalejo A, Jaeger P, Aguilera-Tejero E, Rodriguez M, Felsenfeld A, Almaden Y. Calcium deficiency reduces circulating levels of FGF23. J Am Soc Nephrol. 2012; 23: 1190-1197. doi: 10.1681/ASN.2011101006
26. Mizobuchi M, Ogata H, Hosaka N, Kumata C, Nakazawa A, Kondo F, Koiwa F, Kinugasa E, Akizawa T. Effects of calcimimetic combined with an angiotensin-converting enzyme inhibitor on uremic cardiomyopathy progression. Am J Nephrol. 2011; 34: 256-267. doi: 10.1159/000330188
27. Choi SR, Lim JH, Kim MY, Hong YA, Chung BH, Chung S, Choi BS, Yang CW, Kim YS, Chang YS, Park CW. Cinacalcet improves endothelial dysfunction and cardiac hypertrophy in patients on hemodialysis with secondary hyperparathyroidism. Nephron Clin Pract. 2012; 122: 1-8. doi: 10.1159/000347145
28. Moe SM, Seifert MF, Chen NX, Sinders RM, Chen X, Duan D, Henley C, Martin D, Gattone VH 2nd. R-568 reduces ectopic calcification in a rat model of chronic kidney disease-mineral bone disorder (CKD-MBD). Nephrol Dial Transplant. 2009; 24: 2371-2377. doi: 10.1093/ndt/gfp078
29. Lopez I, Aguilera-Tejero E, Mendoza FJ, Almaden Y, Perez J, Martin D, Rodriguez M. Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol. J Am Soc Nephrol. 2006; 17: 795-804. doi: 10.1681/ASN.2005040342
30. Lopez I, Mendoza FJ, Aguilera-Tejero E, Perez J, Guerrero F, Martin D, Rodriguez M. The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats. Kidney Int. 2008; 73: 300-307. doi: 10.1038/sj.ki.5002675
31. Raggi P, Chertow GM, Torres PU, Csiky B, Naso A, Nossuli K, Moustafa M, Goodman WG, Lopez N, Downey G, Dehmel B, Floege J. ADVANCE Study Group The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant. 2011; 26: 1327-1339. doi: 10.1093/ndt/gfq725
32. Mirza MA, Larsson A, Lind L, Larsson TE. Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis. 2009; 205: 385-390. doi: 10.1016/j. atherosclerosis.2009.01.001
33. Ivanovski O, Nikolov IG, Joki N, Caudrillier A, Phan O, Mentaverri R, Maizel J, Hamada Y, Nguyen-Khoa T, Fukagawa M, Kamel S, Lacour B, Drüeke TB, Massy ZA. The calcimimetic R-568 retards uremiaenhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice. Atherosclerosis. 2009; 205: 55-62. doi: 10.1016/j. atherosclerosis.2008.10.043
34. Hénaut L, Boudot C, Massy ZA, Lopez-Fernandez I, Dupont S, Mary A, Drüeke TB, Kamel S, Brazier M, Mentaverri R. Calcimimetics increase CaSR expression and reduce mineralization in vascular smooth muscle cells: mechanisms of action. Cardiovasc Res. 2014; 101: 256-265. doi: 10.1093/cvr/cvt249
35. Tfelt-Hansen J, Hansen JL, Smajilovic S, Terwilliger EF, Haunso S, Sheikh SP. Calcium receptor is functionally expressed in rat neonatal ventricular cardiomyocytes. Am J Physiol Heart Circ Physiol. 2006; 290: H1165-H1171. doi: 10.1152/ajpheart.00821.2005